Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects

Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection....

Full description

Saved in:
Bibliographic Details
Published inInfection, genetics and evolution Vol. 98; p. 105207
Main Authors Abdolahi, Shahrokh, Hosseini, Maryam, Rezaei, Ramazan, Mohebbi, Seyed Reza, Rostami-Nejad, Mohammad, Mojarad, Ehsan Nazemalhosseini, Mirjalali, Hamed, Yadegar, Abbas, Asadzadeh Aghdaei, Hamid, Zali, Mohamad Reza, Baghaei, Kaveh
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.03.2022
The Authors. Published by Elsevier B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection. •miRNAs could serve as a novel prognostic marker for SARS-CoV-2 infection.•hsa-miR-200c-3p directly targets ACE2 mRNA leading to decreased ACE2 expression.•miR-421-5p cause a balance between inflammatory and anti-inflammatory processes.•Assessing the levels of miRNA 200c and 451-5p could be important for coronavirus COVID-19 (SARS-CoV-2) patients.
AbstractList Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection.Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection.
Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection. •miRNAs could serve as a novel prognostic marker for SARS-CoV-2 infection.•hsa-miR-200c-3p directly targets ACE2 mRNA leading to decreased ACE2 expression.•miR-421-5p cause a balance between inflammatory and anti-inflammatory processes.•Assessing the levels of miRNA 200c and 451-5p could be important for coronavirus COVID-19 (SARS-CoV-2) patients.
Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are considered to modulate the expression of ACE2 gene and alterations in the expression of these miRNAs may influence the outcomes of COVID-19 infection. Accordingly, we examined whether miRNAs directing ACE2 expression altered in the SARS-CoV-2 infection. 30 patients with COVID-19 included in the study. At the time of admission and discharge, the expression of miR-200c-3p and miR-421-5p, inflammatory cytokine IL-6, and regulatory T cells' expression profiles (CD4, CD25, and Foxp3) were examined using quantitative real-time PCR method. At the time of admission, the expression levels of miR-200c-3p and miR-421-5p as well as CD4, CD25, and Foxp3 significantly decreased while IL-6 expression notably enhanced. However, by the time of discharge, the expression levels of the genes were opposite to the time of admission. Moreover, Pearson correlation analysis indicated that IL-6 expression negatively correlated with Foxp3 and miR-200c-3p expressions despite miR-421-5p and miR-200c-3p positively correlated at admission time. By manipulating miR-200c-3p and miR-421-5p expressions and controlling the ACE2 level, it is plausible to modulate the inflammation by reducing IL-6 and maintenance tolerance hemostasis during COVID-19 infection.
ArticleNumber 105207
Author Mohebbi, Seyed Reza
Abdolahi, Shahrokh
Hosseini, Maryam
Mojarad, Ehsan Nazemalhosseini
Zali, Mohamad Reza
Baghaei, Kaveh
Rezaei, Ramazan
Asadzadeh Aghdaei, Hamid
Mirjalali, Hamed
Rostami-Nejad, Mohammad
Yadegar, Abbas
Author_xml – sequence: 1
  givenname: Shahrokh
  surname: Abdolahi
  fullname: Abdolahi, Shahrokh
  organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 2
  givenname: Maryam
  surname: Hosseini
  fullname: Hosseini, Maryam
  organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 3
  givenname: Ramazan
  surname: Rezaei
  fullname: Rezaei, Ramazan
  organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 4
  givenname: Seyed Reza
  surname: Mohebbi
  fullname: Mohebbi, Seyed Reza
  organization: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 5
  givenname: Mohammad
  surname: Rostami-Nejad
  fullname: Rostami-Nejad, Mohammad
  organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 6
  givenname: Ehsan Nazemalhosseini
  surname: Mojarad
  fullname: Mojarad, Ehsan Nazemalhosseini
  organization: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 7
  givenname: Hamed
  surname: Mirjalali
  fullname: Mirjalali, Hamed
  organization: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 8
  givenname: Abbas
  surname: Yadegar
  fullname: Yadegar, Abbas
  organization: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 9
  givenname: Hamid
  surname: Asadzadeh Aghdaei
  fullname: Asadzadeh Aghdaei, Hamid
  organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 10
  givenname: Mohamad Reza
  surname: Zali
  fullname: Zali, Mohamad Reza
  organization: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
– sequence: 11
  givenname: Kaveh
  surname: Baghaei
  fullname: Baghaei, Kaveh
  email: kavehbaghai@gmail.com
  organization: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34999004$$D View this record in MEDLINE/PubMed
BookMark eNqNUktv1DAYjFARfcA_QMhHLln8ip1wQEJLgUqVKiHgajn2l61Xib3YTir-Pe7uFgEH4GR_9sxo7Jnz6sQHD1X1nOAVwUS82q4mgI2zK4opLUcNxfJRdUYaIWtJG3ly3BPG29PqPKUtxkRi2j6pThnvug5jflbdXS56nHV2waMwoMl9qinGpmY7pL3dz5ySutmhERYYE7JzdH6D3DTNHlCEtAs-QULOo3wLSNvJ5Qx2z45gwgKxTOubr1fvatKhNPdbMDk9rR4Pekzw7LheVF_eX35ef6yvbz5crd9e14Z3ItekN7xpMB8ktn1rNTAYJOmE6QVwzAbeajMIbrHWDKg1pAWNuaWmPFV0INlF9eagu5v7CawBn6Me1S66ScfvKminfr_x7lZtwqJaybBkogi8PArE8G2GlNXkkoFx1B7CnBQVvG2Z6AT-DyhpS0qMkwJ98autn34egimA1weAiSGlCIMyLu9jKi7dqAhW9y1QW3VogbpvgTq0oJD5H-QH_X_Qjn9VcobFQVTJOPAGrCtJZmWD-7vAD3XIzPo
CitedBy_id crossref_primary_10_3390_ijms232415659
crossref_primary_10_1007_s11033_024_09630_2
crossref_primary_10_5812_ijpr_137832
crossref_primary_10_1016_j_jve_2025_100586
crossref_primary_10_3390_life12121964
crossref_primary_10_7759_cureus_57008
crossref_primary_10_1186_s12879_025_10803_y
crossref_primary_10_1039_D2SD00140C
crossref_primary_10_3390_ijms24043574
crossref_primary_10_3390_ncrna8030029
crossref_primary_10_3390_life12040575
crossref_primary_10_3390_biom13091344
crossref_primary_10_1038_s41392_023_01669_0
crossref_primary_10_3390_ijms26072881
crossref_primary_10_3389_fdmed_2024_1438139
crossref_primary_10_3390_cells11152279
Cites_doi 10.1002/jcp.30047
10.7150/ijms.46695
10.1007/s00134-020-05985-9
10.1172/jci.insight.137799
10.3390/ijms20236008
10.1016/j.cellsig.2014.12.003
10.1111/jvim.15454
10.1038/nature04753
10.1016/j.lfs.2020.118058
10.1172/JCI31202
10.1016/j.cyto.2021.155455
10.1038/nature06306
10.1001/jama.2020.8946
10.1371/journal.pone.0235987
10.1038/nm1267
10.2174/138161207780618867
10.1016/S2213-2600(20)30076-X
10.1002/jcp.28643
10.1016/j.mgene.2020.100831
10.1084/jem.192.2.295
10.1586/1744666X.2014.913482
10.1084/jem.20051166
10.1042/CS20130420
10.1016/j.cytogfr.2020.05.009
10.1016/j.jmii.2020.03.005
10.1073/pnas.0711241105
10.1038/celldisc.2017.21
10.1093/cid/ciaa248
10.1016/j.genrep.2021.101140
10.1016/S0140-6736(20)30183-5
10.1002/path.5471
10.1016/j.ebiom.2020.102763
10.1159/000493805
10.1016/j.cell.2020.02.052
10.1002/eji.201040391
10.1172/JCI137244
10.1128/JVI.01248-09
10.1111/j.1600-0897.2012.01176.x
10.1016/j.yjmcc.2020.08.017
10.1002/jmv.20556
10.1038/s41598-020-76404-8
10.2217/imt.11.79
10.1007/s13277-015-4578-5
10.1016/j.micinf.2009.04.002
10.1056/NEJMoa2002032
10.1002/ppul.23193
ContentType Journal Article
Copyright 2022 The Authors
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
2022 The Authors 2022
Copyright_xml – notice: 2022 The Authors
– notice: Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
– notice: 2022 The Authors 2022
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOI 10.1016/j.meegid.2022.105207
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1567-7257
EndPage 105207
ExternalDocumentID PMC8730736
34999004
10_1016_j_meegid_2022_105207
S1567134822000041
Genre Journal Article
Comparative Study
GeographicLocations Iran
GeographicLocations_xml – name: Iran
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29I
4.4
457
4G.
53G
5GY
5VS
6I.
7-5
71M
8P~
AAAJQ
AABVA
AACTN
AAEDT
AAEDW
AAFTH
AAFWJ
AAIAV
AAIKJ
AAKOC
AALCJ
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATLK
AAXUO
ABBQC
ABFNM
ABFRF
ABGRD
ABGSF
ABLVK
ABMAC
ABMZM
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADQTV
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AEQOU
AFKWA
AFPKN
AFTJW
AFXIZ
AGEKW
AGHFR
AGRDE
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CBWCG
CJTIS
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
GROUPED_DOAJ
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LUGTX
M41
MO0
N9A
O-L
O9-
OAUVE
OK1
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SDP
SES
SEW
SPCBC
SSA
SSH
SSI
SSU
SSZ
T5K
UHS
UNMZH
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACIEU
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
EFKBS
L.6
5PM
ID FETCH-LOGICAL-c496t-1bc45504f70db8dae3ef7196cb6e403f48acf64d0aa3e2dc18ea04d2c01769e73
IEDL.DBID .~1
ISSN 1567-1348
1567-7257
IngestDate Thu Aug 21 14:12:55 EDT 2025
Tue Aug 05 09:03:17 EDT 2025
Fri Jul 11 02:16:30 EDT 2025
Thu Apr 24 04:15:05 EDT 2025
Tue Jul 01 03:46:26 EDT 2025
Thu Apr 24 23:07:32 EDT 2025
Fri Feb 23 02:39:47 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords COVID-19
miR-200c-3p
ACE-2
IL-6
miR-421-5p
Language English
License This is an open access article under the CC BY license.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c496t-1bc45504f70db8dae3ef7196cb6e403f48acf64d0aa3e2dc18ea04d2c01769e73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1567134822000041
PMID 34999004
PQID 2618520341
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8730736
proquest_miscellaneous_2648836960
proquest_miscellaneous_2618520341
pubmed_primary_34999004
crossref_citationtrail_10_1016_j_meegid_2022_105207
crossref_primary_10_1016_j_meegid_2022_105207
elsevier_sciencedirect_doi_10_1016_j_meegid_2022_105207
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-03-01
PublicationDateYYYYMMDD 2022-03-01
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Infection, genetics and evolution
PublicationTitleAlternate Infect Genet Evol
PublicationYear 2022
Publisher Elsevier B.V
The Authors. Published by Elsevier B.V
Publisher_xml – name: Elsevier B.V
– name: The Authors. Published by Elsevier B.V
References Curiel (bb0065) 2007; 117
Glowacka (bb0075) 2010; 84
Kany, Vollrath, Relja (bb0120) 2019; 20
Joshi (bb0115) 2019; 234
Collison (bb0060) 2007; 450
Iwasaki (bb0110) 2020
Ames, Atkins, Pitt (bb0010) 2019; 33
Hajivalili, Hosseini, Haji-Fatahaliha (bb0095) 2020; 257
Trojanowicz (bb0240) 2019; 141
Haga (bb0090) 2008; 105
Bettelli (bb0030) 2006; 441
Chen (bb0050) 2020; 130
Bergantini (bb0025) 2021; 141
Organization, W.H (bb0190) 2020; 182
Lu (bb0165) 2020; 148
Zhang (bb0275) 2020; 46
Abul Bashar Mir Md Khademul, Khan (bb0005) 2020; 10
Kuba (bb0135) 2005; 11
Read, Malmström, Powrie (bb0215) 2000; 192
Zhou (bb0280) 2016; 37
Wang (bb0250) 2020; 17
Hoffmann (bb0100) 2020; 181
Nersisyan (bb0175) 2020; 15
Lim (bb0150) 2020
Bao (bb0020) 2021; 25
Rossi, Silvestri, Colin (bb0220) 2015; 50
Trojanowicz (bb0235) 2017; 32
Xu (bb0270) 2020; 8
Chen (bb0045) 2011; 3
Li (bb0145) 2007; 13
Kimura, Kishimoto (bb0130) 2010; 40
Kearley (bb0125) 2005; 202
Wu, Yang (bb0260) 2020; 53
Pimenta (bb0205) 2021; 10
Papannarao (bb0195) 2021
Chi (bb0055) 2020
Gubernatorova (bb0085) 2020; 53
Patel, Verma (bb0200) 2020; 323
Liu (bb0155) 2017; 3
Ziegler, Buckner (bb0285) 2009; 11
Guan (bb0080) 2020; 382
Qin (bb0210) 2020; 71
Wang (bb0245) 2015; 27
Liu (bb0160) 2020; 55
Balandya (bb0015) 2012; 68
Głobińska, Pawełczyk, Kowalski (bb0070) 2014; 10
Huang (bb0105) 2020; 395
Soltani-Zangbar (bb0230) 2021; 23
Lambert (bb0140) 2014; 127
Bozgeyik (bb0040) 2021; 27
Wang (bb0255) 2020; 5
Okabayashi (bb0180) 2006; 78
Sadeghi (bb0225) 2020; 236
Onabajo (bb0185) 2020
Mohebbi (bb0170) 2020; 13
Bourgonje (bb0035) 2020; 251
Kany (10.1016/j.meegid.2022.105207_bb0120) 2019; 20
Rossi (10.1016/j.meegid.2022.105207_bb0220) 2015; 50
Sadeghi (10.1016/j.meegid.2022.105207_bb0225) 2020; 236
Lambert (10.1016/j.meegid.2022.105207_bb0140) 2014; 127
Wang (10.1016/j.meegid.2022.105207_bb0245) 2015; 27
Trojanowicz (10.1016/j.meegid.2022.105207_bb0240) 2019; 141
Abul Bashar Mir Md Khademul (10.1016/j.meegid.2022.105207_bb0005) 2020; 10
Huang (10.1016/j.meegid.2022.105207_bb0105) 2020; 395
Nersisyan (10.1016/j.meegid.2022.105207_bb0175) 2020; 15
Okabayashi (10.1016/j.meegid.2022.105207_bb0180) 2006; 78
Bao (10.1016/j.meegid.2022.105207_bb0020) 2021; 25
Bergantini (10.1016/j.meegid.2022.105207_bb0025) 2021; 141
Chi (10.1016/j.meegid.2022.105207_bb0055) 2020
Curiel (10.1016/j.meegid.2022.105207_bb0065) 2007; 117
Zhou (10.1016/j.meegid.2022.105207_bb0280) 2016; 37
Xu (10.1016/j.meegid.2022.105207_bb0270) 2020; 8
Onabajo (10.1016/j.meegid.2022.105207_bb0185) 2020
Hajivalili (10.1016/j.meegid.2022.105207_bb0095) 2020; 257
Haga (10.1016/j.meegid.2022.105207_bb0090) 2008; 105
Liu (10.1016/j.meegid.2022.105207_bb0160) 2020; 55
Bozgeyik (10.1016/j.meegid.2022.105207_bb0040) 2021; 27
Hoffmann (10.1016/j.meegid.2022.105207_bb0100) 2020; 181
Patel (10.1016/j.meegid.2022.105207_bb0200) 2020; 323
Trojanowicz (10.1016/j.meegid.2022.105207_bb0235) 2017; 32
Papannarao (10.1016/j.meegid.2022.105207_bb0195) 2021
Collison (10.1016/j.meegid.2022.105207_bb0060) 2007; 450
Liu (10.1016/j.meegid.2022.105207_bb0155) 2017; 3
Soltani-Zangbar (10.1016/j.meegid.2022.105207_bb0230) 2021; 23
Joshi (10.1016/j.meegid.2022.105207_bb0115) 2019; 234
Read (10.1016/j.meegid.2022.105207_bb0215) 2000; 192
Głobińska (10.1016/j.meegid.2022.105207_bb0070) 2014; 10
Chen (10.1016/j.meegid.2022.105207_bb0050) 2020; 130
Lim (10.1016/j.meegid.2022.105207_bb0150) 2020
Chen (10.1016/j.meegid.2022.105207_bb0045) 2011; 3
Iwasaki (10.1016/j.meegid.2022.105207_bb0110) 2020
Zhang (10.1016/j.meegid.2022.105207_bb0275) 2020; 46
Ames (10.1016/j.meegid.2022.105207_bb0010) 2019; 33
Kuba (10.1016/j.meegid.2022.105207_bb0135) 2005; 11
Bourgonje (10.1016/j.meegid.2022.105207_bb0035) 2020; 251
Gubernatorova (10.1016/j.meegid.2022.105207_bb0085) 2020; 53
Glowacka (10.1016/j.meegid.2022.105207_bb0075) 2010; 84
Organization, W.H (10.1016/j.meegid.2022.105207_bb0190) 2020; 182
Pimenta (10.1016/j.meegid.2022.105207_bb0205) 2021; 10
Kimura (10.1016/j.meegid.2022.105207_bb0130) 2010; 40
Balandya (10.1016/j.meegid.2022.105207_bb0015) 2012; 68
Bettelli (10.1016/j.meegid.2022.105207_bb0030) 2006; 441
Mohebbi (10.1016/j.meegid.2022.105207_bb0170) 2020; 13
Ziegler (10.1016/j.meegid.2022.105207_bb0285) 2009; 11
Li (10.1016/j.meegid.2022.105207_bb0145) 2007; 13
Lu (10.1016/j.meegid.2022.105207_bb0165) 2020; 148
Wang (10.1016/j.meegid.2022.105207_bb0255) 2020; 5
Kearley (10.1016/j.meegid.2022.105207_bb0125) 2005; 202
Wang (10.1016/j.meegid.2022.105207_bb0250) 2020; 17
Qin (10.1016/j.meegid.2022.105207_bb0210) 2020; 71
Wu (10.1016/j.meegid.2022.105207_bb0260) 2020; 53
Guan (10.1016/j.meegid.2022.105207_bb0080) 2020; 382
References_xml – volume: 23
  year: 2021
  ident: bb0230
  article-title: Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation
  publication-title: Gene Reports
– volume: 192
  start-page: 295
  year: 2000
  end-page: 302
  ident: bb0215
  article-title: Cytotoxic T lymphocyte–associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation
  publication-title: J. Exp. Med.
– volume: 141
  year: 2021
  ident: bb0025
  article-title: Prognostic bioindicators in severe COVID-19 patients
  publication-title: Cytokine
– volume: 181
  start-page: 271
  year: 2020
  end-page: 280
  ident: bb0100
  article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
  publication-title: Cell
– volume: 234
  start-page: 20420
  year: 2019
  end-page: 20431
  ident: bb0115
  article-title: Hypoxic regulation of angiotensin-converting enzyme 2 and mas receptor in human CD34+ cells
  publication-title: J. Cell. Physiol.
– start-page: 1
  year: 2020
  end-page: 22
  ident: bb0110
  article-title: Inflammation triggered by sars-cov-2 and ace2 augment drives multiple organ failure of severe covid-19: molecular mechanisms and implications
  publication-title: Inflammation
– volume: 10
  start-page: 963
  year: 2014
  end-page: 971
  ident: bb0070
  article-title: MicroRNAs and the immune response to respiratory virus infections
  publication-title: Expert. Rev. Clin. Immunol.
– volume: 13
  start-page: 1257
  year: 2007
  end-page: 1268
  ident: bb0145
  article-title: Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA
  publication-title: Curr. Pharm. Des.
– volume: 20
  start-page: 6008
  year: 2019
  ident: bb0120
  article-title: Cytokines in inflammatory disease
  publication-title: Int. J. Mol. Sci.
– volume: 13
  start-page: 388
  year: 2020
  ident: bb0170
  article-title: Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients
  publication-title: Gastroenterology and hepatology from bed to bench
– volume: 71
  start-page: 762
  year: 2020
  end-page: 768
  ident: bb0210
  article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China
  publication-title: Clinical infectious diseases
– volume: 50
  start-page: 727
  year: 2015
  end-page: 732
  ident: bb0220
  article-title: Respiratory syncytial virus infection of airway cells: role of microRNAs
  publication-title: Pediatr. Pulmonol.
– volume: 382
  start-page: 1708
  year: 2020
  end-page: 1720
  ident: bb0080
  article-title: Clinical characteristics of coronavirus disease 2019 in China
  publication-title: N. Engl. J. Med.
– volume: 3
  start-page: 1
  year: 2017
  end-page: 17
  ident: bb0155
  article-title: miRNA-200c-3p is crucial in acute respiratory distress syndrome
  publication-title: Cell Discovery
– volume: 236
  start-page: 2829
  year: 2020
  end-page: 2839
  ident: bb0225
  article-title: Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls
  publication-title: J. Cell. Physiol.
– volume: 127
  start-page: 243
  year: 2014
  end-page: 249
  ident: bb0140
  article-title: Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421
  publication-title: Clin. Sci.
– volume: 8
  start-page: 420
  year: 2020
  end-page: 422
  ident: bb0270
  article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome
  publication-title: Lancet Respir. Med.
– volume: 17
  start-page: 1522
  year: 2020
  ident: bb0250
  article-title: A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells
  publication-title: Int. J. Med. Sci.
– year: 2020
  ident: bb0055
  article-title: The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R)
  publication-title: Antagonist Tocilizumab man be the Key to Reduce the Mortality
– volume: 182
  year: 2020
  ident: bb0190
  article-title: Coronavirus Disease (COVID-19): Situation Report
– volume: 148
  start-page: 46
  year: 2020
  end-page: 49
  ident: bb0165
  article-title: MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
  publication-title: J. Mol. Cell. Cardiol.
– volume: 68
  start-page: 322
  year: 2012
  end-page: 330
  ident: bb0015
  article-title: Human seminal plasma fosters CD 4+ regulatory T-cell phenotype and transforming growth factor-β1 expression
  publication-title: Am J Reprod Immunol
– volume: 55
  year: 2020
  ident: bb0160
  article-title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
  publication-title: EBioMedicine
– volume: 202
  start-page: 1539
  year: 2005
  end-page: 1547
  ident: bb0125
  article-title: Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent
  publication-title: J Exp Med
– volume: 10
  start-page: 19395
  year: 2020
  ident: bb0005
  article-title: Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy
  publication-title: Sci. Rep.
– volume: 450
  start-page: 566
  year: 2007
  end-page: 569
  ident: bb0060
  article-title: The inhibitory cytokine IL-35 contributes to regulatory T-cell function
  publication-title: Nature
– volume: 78
  start-page: 417
  year: 2006
  end-page: 424
  ident: bb0180
  article-title: Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections
  publication-title: J. Med. Virol.
– volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  ident: bb0105
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: The Lancet
– volume: 40
  start-page: 1830
  year: 2010
  end-page: 1835
  ident: bb0130
  article-title: IL-6: regulator of Treg/Th17 balance
  publication-title: Eur. J. Immunol.
– volume: 53
  start-page: 13
  year: 2020
  end-page: 24
  ident: bb0085
  article-title: IL-6: relevance for immunopathology of SARS-CoV-2
  publication-title: Cytokine Growth Factor Rev.
– volume: 441
  start-page: 235
  year: 2006
  end-page: 238
  ident: bb0030
  article-title: Reciprocal developmental pathways for the generation of pathogenic effector TH 17 and regulatory T cells
  publication-title: Nature
– volume: 3
  start-page: 911
  year: 2011
  end-page: 914
  ident: bb0045
  article-title: Tregs in immunotherapy: opportunities and challenges
  publication-title: Immunotherapy
– volume: 32
  start-page: 287
  year: 2017
  end-page: 298
  ident: bb0235
  article-title: Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease
  publication-title: Nephrology Dialysis Transplantation
– volume: 5
  year: 2020
  ident: bb0255
  article-title: The laboratory tests and host immunity of COVID-19 patients with different severity of illness
  publication-title: JCI Insight
– volume: 53
  start-page: 368
  year: 2020
  end-page: 370
  ident: bb0260
  article-title: TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib
  publication-title: J. Microbiol. Immunol. Infect.
– volume: 141
  start-page: 61
  year: 2019
  end-page: 74
  ident: bb0240
  article-title: Circulating miR-421 targeting leucocytic angiotensin converting enzyme 2 is elevated in patients with chronic kidney disease
  publication-title: Nephron
– volume: 84
  start-page: 1198
  year: 2010
  end-page: 1205
  ident: bb0075
  article-title: Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63
  publication-title: J. Virol.
– volume: 37
  start-page: 9001
  year: 2016
  end-page: 9007
  ident: bb0280
  article-title: miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma
  publication-title: Tumor Biol.
– volume: 27
  start-page: 443
  year: 2015
  end-page: 452
  ident: bb0245
  article-title: Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
  publication-title: Cell. Signal.
– volume: 25
  start-page: 527
  year: 2021
  end-page: 540
  ident: bb0020
  article-title: High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19
  publication-title: Eur Rev Med Pharmacol Sci.
– volume: 27
  year: 2021
  ident: bb0040
  article-title: Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2
  publication-title: Meta gene
– volume: 257
  year: 2020
  ident: bb0095
  article-title: Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges
  publication-title: Life Sci.
– volume: 130
  start-page: 2620
  year: 2020
  end-page: 2629
  ident: bb0050
  article-title: Clinical and immunological features of severe and moderate coronavirus disease 2019
  publication-title: J. Clin. Invest.
– volume: 105
  start-page: 7809
  year: 2008
  end-page: 7814
  ident: bb0090
  article-title: Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
  publication-title: Proc. Natl. Acad. Sci.
– volume: 323
  start-page: 2386
  year: 2020
  end-page: 2387
  ident: bb0200
  article-title: Nasal ACE2 levels and COVID-19 in children
  publication-title: JAMA
– volume: 251
  start-page: 228
  year: 2020
  end-page: 248
  ident: bb0035
  article-title: Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)
  publication-title: J. Pathol.
– volume: 11
  start-page: 875
  year: 2005
  end-page: 879
  ident: bb0135
  article-title: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
  publication-title: Nat. Med.
– volume: 10
  start-page: 141
  year: 2021
  ident: bb0205
  article-title: MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19
  publication-title: Mol Biol Res Commun
– volume: 117
  start-page: 1167
  year: 2007
  end-page: 1174
  ident: bb0065
  article-title: Tregs and rethinking cancer immunotherapy
  publication-title: J Clin Invest.
– volume: 15
  year: 2020
  ident: bb0175
  article-title: Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2
  publication-title: PLoS One
– start-page: 1
  year: 2020
  end-page: 11
  ident: bb0185
  article-title: Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
  publication-title: Nat. Genet.
– volume: 33
  start-page: 363
  year: 2019
  end-page: 382
  ident: bb0010
  article-title: The renin-angiotensin-aldosterone system and its suppression
  publication-title: J. Vet. Intern. Med.
– volume: 11
  start-page: 594
  year: 2009
  end-page: 598
  ident: bb0285
  article-title: FOXP3 and the regulation of Treg/Th17 differentiation
  publication-title: Microbes Infect.
– volume: 46
  start-page: 586
  year: 2020
  end-page: 590
  ident: bb0275
  article-title: Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
  publication-title: Intensive Care Med.
– year: 2021
  ident: bb0195
  article-title: Upregulated miR-200c may increase the risk of obese individuals to severe COVID-19
  publication-title: medRxiv
– start-page: 1
  year: 2020
  end-page: 20
  ident: bb0150
  article-title: COVID-19 and diabetes mellitus: from pathophysiology to clinical management
  publication-title: Nat. Rev. Endocrinol.
– volume: 236
  start-page: 2829
  issue: 4
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0225
  article-title: Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.30047
– year: 2021
  ident: 10.1016/j.meegid.2022.105207_bb0195
  article-title: Upregulated miR-200c may increase the risk of obese individuals to severe COVID-19
  publication-title: medRxiv
– volume: 17
  start-page: 1522
  issue: 11
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0250
  article-title: A comprehensive investigation of the mRNA and protein level of ACE2, the putative receptor of SARS-CoV-2, in human tissues and blood cells
  publication-title: Int. J. Med. Sci.
  doi: 10.7150/ijms.46695
– volume: 46
  start-page: 586
  issue: 4
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0275
  article-title: Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-020-05985-9
– volume: 5
  issue: 10
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0255
  article-title: The laboratory tests and host immunity of COVID-19 patients with different severity of illness
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.137799
– volume: 20
  start-page: 6008
  issue: 23
  year: 2019
  ident: 10.1016/j.meegid.2022.105207_bb0120
  article-title: Cytokines in inflammatory disease
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20236008
– volume: 27
  start-page: 443
  issue: 3
  year: 2015
  ident: 10.1016/j.meegid.2022.105207_bb0245
  article-title: Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
  publication-title: Cell. Signal.
  doi: 10.1016/j.cellsig.2014.12.003
– volume: 33
  start-page: 363
  issue: 2
  year: 2019
  ident: 10.1016/j.meegid.2022.105207_bb0010
  article-title: The renin-angiotensin-aldosterone system and its suppression
  publication-title: J. Vet. Intern. Med.
  doi: 10.1111/jvim.15454
– volume: 441
  start-page: 235
  issue: 7090
  year: 2006
  ident: 10.1016/j.meegid.2022.105207_bb0030
  article-title: Reciprocal developmental pathways for the generation of pathogenic effector TH 17 and regulatory T cells
  publication-title: Nature
  doi: 10.1038/nature04753
– volume: 257
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0095
  article-title: Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2020.118058
– volume: 117
  start-page: 1167
  issue: 5
  year: 2007
  ident: 10.1016/j.meegid.2022.105207_bb0065
  article-title: Tregs and rethinking cancer immunotherapy
  publication-title: J Clin Invest.
  doi: 10.1172/JCI31202
– volume: 141
  year: 2021
  ident: 10.1016/j.meegid.2022.105207_bb0025
  article-title: Prognostic bioindicators in severe COVID-19 patients
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2021.155455
– volume: 450
  start-page: 566
  issue: 7169
  year: 2007
  ident: 10.1016/j.meegid.2022.105207_bb0060
  article-title: The inhibitory cytokine IL-35 contributes to regulatory T-cell function
  publication-title: Nature
  doi: 10.1038/nature06306
– volume: 323
  start-page: 2386
  issue: 23
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0200
  article-title: Nasal ACE2 levels and COVID-19 in children
  publication-title: JAMA
  doi: 10.1001/jama.2020.8946
– volume: 15
  issue: 7
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0175
  article-title: Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0235987
– volume: 11
  start-page: 875
  issue: 8
  year: 2005
  ident: 10.1016/j.meegid.2022.105207_bb0135
  article-title: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
  publication-title: Nat. Med.
  doi: 10.1038/nm1267
– volume: 13
  start-page: 1257
  issue: 12
  year: 2007
  ident: 10.1016/j.meegid.2022.105207_bb0145
  article-title: Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/138161207780618867
– volume: 8
  start-page: 420
  issue: 4
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0270
  article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome
  publication-title: Lancet Respir. Med.
  doi: 10.1016/S2213-2600(20)30076-X
– volume: 234
  start-page: 20420
  issue: 11
  year: 2019
  ident: 10.1016/j.meegid.2022.105207_bb0115
  article-title: Hypoxic regulation of angiotensin-converting enzyme 2 and mas receptor in human CD34+ cells
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.28643
– volume: 27
  year: 2021
  ident: 10.1016/j.meegid.2022.105207_bb0040
  article-title: Therapeutic potential of miRNAs targeting SARS-CoV-2 host cell receptor ACE2
  publication-title: Meta gene
  doi: 10.1016/j.mgene.2020.100831
– volume: 192
  start-page: 295
  issue: 2
  year: 2000
  ident: 10.1016/j.meegid.2022.105207_bb0215
  article-title: Cytotoxic T lymphocyte–associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.192.2.295
– volume: 10
  start-page: 963
  issue: 7
  year: 2014
  ident: 10.1016/j.meegid.2022.105207_bb0070
  article-title: MicroRNAs and the immune response to respiratory virus infections
  publication-title: Expert. Rev. Clin. Immunol.
  doi: 10.1586/1744666X.2014.913482
– volume: 202
  start-page: 1539
  issue: 11
  year: 2005
  ident: 10.1016/j.meegid.2022.105207_bb0125
  article-title: Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent
  publication-title: J Exp Med
  doi: 10.1084/jem.20051166
– volume: 25
  start-page: 527
  issue: 1
  year: 2021
  ident: 10.1016/j.meegid.2022.105207_bb0020
  article-title: High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19
  publication-title: Eur Rev Med Pharmacol Sci.
– volume: 127
  start-page: 243
  issue: 4
  year: 2014
  ident: 10.1016/j.meegid.2022.105207_bb0140
  article-title: Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421
  publication-title: Clin. Sci.
  doi: 10.1042/CS20130420
– year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0055
  article-title: The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R)
– volume: 32
  start-page: 287
  issue: 2
  year: 2017
  ident: 10.1016/j.meegid.2022.105207_bb0235
  article-title: Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease
  publication-title: Nephrology Dialysis Transplantation
– volume: 53
  start-page: 13
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0085
  article-title: IL-6: relevance for immunopathology of SARS-CoV-2
  publication-title: Cytokine Growth Factor Rev.
  doi: 10.1016/j.cytogfr.2020.05.009
– volume: 53
  start-page: 368
  issue: 3
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0260
  article-title: TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib
  publication-title: J. Microbiol. Immunol. Infect.
  doi: 10.1016/j.jmii.2020.03.005
– volume: 105
  start-page: 7809
  issue: 22
  year: 2008
  ident: 10.1016/j.meegid.2022.105207_bb0090
  article-title: Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.0711241105
– volume: 3
  start-page: 1
  issue: 1
  year: 2017
  ident: 10.1016/j.meegid.2022.105207_bb0155
  article-title: miRNA-200c-3p is crucial in acute respiratory distress syndrome
  publication-title: Cell Discovery
  doi: 10.1038/celldisc.2017.21
– start-page: 1
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0110
  article-title: Inflammation triggered by sars-cov-2 and ace2 augment drives multiple organ failure of severe covid-19: molecular mechanisms and implications
  publication-title: Inflammation
– volume: 71
  start-page: 762
  issue: 15
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0210
  article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China
  publication-title: Clinical infectious diseases
  doi: 10.1093/cid/ciaa248
– volume: 23
  year: 2021
  ident: 10.1016/j.meegid.2022.105207_bb0230
  article-title: Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation
  publication-title: Gene Reports
  doi: 10.1016/j.genrep.2021.101140
– volume: 395
  start-page: 497
  issue: 10223
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0105
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 251
  start-page: 228
  issue: 3
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0035
  article-title: Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)
  publication-title: J. Pathol.
  doi: 10.1002/path.5471
– volume: 55
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0160
  article-title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2020.102763
– volume: 10
  start-page: 141
  issue: 3
  year: 2021
  ident: 10.1016/j.meegid.2022.105207_bb0205
  article-title: MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19
  publication-title: Mol Biol Res Commun
– volume: 141
  start-page: 61
  issue: 1
  year: 2019
  ident: 10.1016/j.meegid.2022.105207_bb0240
  article-title: Circulating miR-421 targeting leucocytic angiotensin converting enzyme 2 is elevated in patients with chronic kidney disease
  publication-title: Nephron
  doi: 10.1159/000493805
– volume: 181
  start-page: 271
  issue: 2
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0100
  article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
  publication-title: Cell
  doi: 10.1016/j.cell.2020.02.052
– volume: 40
  start-page: 1830
  issue: 7
  year: 2010
  ident: 10.1016/j.meegid.2022.105207_bb0130
  article-title: IL-6: regulator of Treg/Th17 balance
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.201040391
– start-page: 1
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0150
  article-title: COVID-19 and diabetes mellitus: from pathophysiology to clinical management
  publication-title: Nat. Rev. Endocrinol.
– volume: 130
  start-page: 2620
  issue: 5
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0050
  article-title: Clinical and immunological features of severe and moderate coronavirus disease 2019
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI137244
– volume: 84
  start-page: 1198
  issue: 2
  year: 2010
  ident: 10.1016/j.meegid.2022.105207_bb0075
  article-title: Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63
  publication-title: J. Virol.
  doi: 10.1128/JVI.01248-09
– volume: 13
  start-page: 388
  issue: 4
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0170
  article-title: Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients
  publication-title: Gastroenterology and hepatology from bed to bench
– volume: 68
  start-page: 322
  issue: 4
  year: 2012
  ident: 10.1016/j.meegid.2022.105207_bb0015
  article-title: Human seminal plasma fosters CD 4+ regulatory T-cell phenotype and transforming growth factor-β1 expression
  publication-title: Am J Reprod Immunol
  doi: 10.1111/j.1600-0897.2012.01176.x
– volume: 148
  start-page: 46
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0165
  article-title: MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
  publication-title: J. Mol. Cell. Cardiol.
  doi: 10.1016/j.yjmcc.2020.08.017
– volume: 78
  start-page: 417
  issue: 4
  year: 2006
  ident: 10.1016/j.meegid.2022.105207_bb0180
  article-title: Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.20556
– volume: 10
  start-page: 19395
  issue: 1
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0005
  article-title: Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-76404-8
– volume: 3
  start-page: 911
  issue: 8
  year: 2011
  ident: 10.1016/j.meegid.2022.105207_bb0045
  article-title: Tregs in immunotherapy: opportunities and challenges
  publication-title: Immunotherapy
  doi: 10.2217/imt.11.79
– volume: 182
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0190
– volume: 37
  start-page: 9001
  issue: 7
  year: 2016
  ident: 10.1016/j.meegid.2022.105207_bb0280
  article-title: miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma
  publication-title: Tumor Biol.
  doi: 10.1007/s13277-015-4578-5
– volume: 11
  start-page: 594
  issue: 5
  year: 2009
  ident: 10.1016/j.meegid.2022.105207_bb0285
  article-title: FOXP3 and the regulation of Treg/Th17 differentiation
  publication-title: Microbes Infect.
  doi: 10.1016/j.micinf.2009.04.002
– volume: 382
  start-page: 1708
  issue: 18
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0080
  article-title: Clinical characteristics of coronavirus disease 2019 in China
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa2002032
– start-page: 1
  year: 2020
  ident: 10.1016/j.meegid.2022.105207_bb0185
  article-title: Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
  publication-title: Nat. Genet.
– volume: 50
  start-page: 727
  issue: 7
  year: 2015
  ident: 10.1016/j.meegid.2022.105207_bb0220
  article-title: Respiratory syncytial virus infection of airway cells: role of microRNAs
  publication-title: Pediatr. Pulmonol.
  doi: 10.1002/ppul.23193
SSID ssj0017028
Score 2.402477
Snippet Angiotensin-converting enzyme 2 (ACE2) acts as a key receptor for the spike of SARS-CoV-2. Two main microRNAs (miRs), miR-200c-3p and miR-421-5p, are...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 105207
SubjectTerms ACE-2
Aged
Angiotensin-Converting Enzyme 2 - genetics
COVID-19
COVID-19 - genetics
COVID-19 - immunology
COVID-19 infection
evolution
Female
Gene Expression Regulation
genes
Healthy Volunteers
hemostasis
Humans
IL-6
Immunity - genetics
infection
inflammation
interleukin-6
Iran
Male
microRNA
MicroRNAs - genetics
Middle Aged
miR-200c-3p
miR-421-5p
peptidyl-dipeptidase A
quantitative polymerase chain reaction
SARS-CoV-2 - genetics
SARS-CoV-2 - immunology
Severe acute respiratory syndrome coronavirus 2
Title Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects
URI https://dx.doi.org/10.1016/j.meegid.2022.105207
https://www.ncbi.nlm.nih.gov/pubmed/34999004
https://www.proquest.com/docview/2618520341
https://www.proquest.com/docview/2648836960
https://pubmed.ncbi.nlm.nih.gov/PMC8730736
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqckFCiDfLY2UkrmaT2Gs7x2pptS2iSEBRb5ZfoUHd7KrZbW_97fXYScRCRSWOTsaS4xnPw5lvBqH3UlpDheGEVtqSoPAkMTIzRFalr6ifWpoDUPjzMZ-fsKPT6ekOmvVYGEir7HR_0ulRW3dPJt1uTlZ1PfkWIg8AQgYLFx3diGBnAqT8w_WQ5pGLLPZXBWIC1D18LuZ4Lbz_WUO90KKAhrcFNJW93Tz97X7-mUX5m1k6eIQedv4k3ktLfox2fPMEPUiXcThhjJ6iq_2hpjdeVnhRfwWxtYSusG5cHLMiJ9MVPoccohYn8CKuATzi8UXKo_UtrhscHEas3aJeB1c1zoaQ-hI6fuLZlx-HH0le4nZj4HqnfYZODva_z-ak67hALCv5muTGAsqZVSJzRjrtqa9EOKPWcM8yWjGpbcWZy7SmvnA2l15nzBU27DMvvaDP0W6zbPxLhP3UUR1MXym5ZZZanTlWWVGK4J9YSfkI0X6jle3KkUNXjHPV5539Uok9CtijEntGiAyzVqkcxx30oueh2hIrFSzGHTPf9SxX4cTBbxTd-OWmVSHmlIEimP9_0QTFCK0SsxF6kcRkWC-FIDMIbFjblgANBFDxe_tNU5_Fyt9SgErmr_77q16j-zBKSXRv0O76YuPfBq9qbcbx2IzRvb3DT_PjcbybuAGbUyJM
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcgAJIcpzeRqJq9kk9trOsVpabaEtErSoN8tx7BLUza6aXbj1tzMTJ1EXEJU4Jh5Ljmc8D2dmPkLeau0KrgrJeLCOgcLTrNBJwXTIfeB-4niKhcJHx3J2Kj6cTc62yLSvhcG0yk73R53eauvuzbjbzfGyqsZfIPLAQkiwcK2jCyHQLQHHF2EM3l0NeR6pSlqAVaRmSN7Xz7VJXnPvzytsGJpliHibIars3-3Tn_7n72mU1-zS_n1yr3Mo6W5c8w7Z8vUDcjfextFYZPSQ_NwbmnrTRaDz6jPKrWN8SW1dts8iS9lkSS8wiaihsXqRVlg94ullTKT1Da1qCh4jteW8WoGv2s7GmPoHQn7S6aevB-9ZmtNmXeD9TvOInO7vnUxnrINcYE7kcsXSwmGZswgqKQtdWs99UHBIXSG9SHgQ2rogRZlYy31WulR7m4gyc7DPMveKPybb9aL2Twn1k5JbsH25lk447mxSiuBUrsBBcZrLEeH9RhvX9SNHWIwL0yeefTeRPQbZYyJ7RoQNs5axH8cN9KrnodmQKwMm44aZb3qWGzhy-B_F1n6xbgwEnRoowP7_iwY0I2IlJiPyJIrJsF6OUSZILKxtQ4AGAmz5vTlSV9_a1t9aoU6Wz_77q16T27OTo0NzeHD88Tm5gyMxo-4F2V5drv1LcLFWxav2CP0CNMIi5Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+miR-200c-3p+and+miR-421-5p+levels+during+immune+responses+in+the+admitted+and+recovered+COVID-19+subjects&rft.jtitle=Infection%2C+genetics+and+evolution&rft.au=Abdolahi%2C+Shahrokh&rft.au=Hosseini%2C+Maryam&rft.au=Rezaei%2C+Ramazan&rft.au=Mohebbi%2C+Seyed+Reza&rft.date=2022-03-01&rft.issn=1567-7257&rft.eissn=1567-7257&rft.volume=98&rft.spage=105207&rft_id=info:doi/10.1016%2Fj.meegid.2022.105207&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1567-1348&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1567-1348&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1567-1348&client=summon